03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
pms-Candesartan HCTZ : | |
Type | Medicine Non Marketed |
Originator | Atacand Plus 16/12.5mg |
Agent | UPO |
Distributor | UPO |
Laboratory | Pharmascience |
Responsible Party | Pharmascience Inc |
Origin | Canada |
Manufacturer | Siegfrid |
Manufacturing Type | G |
Origin | Malta |
ATC | C09DA06 |
pms-Candesartan HCTZ :
pms-Candesartan HCTZ :
pms-Candesartan HCTZ :
pms-Candesartan HCTZ :
pms-Candesartan HCTZ :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
pms-Candesartan HCTZ :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Agitation | Rare |
Agranulocytosis | Very rare |
ALT increased | Uncommon |
Anaphylactic reactions | Rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Anorexia | Uncommon |
Aplastic anemia | Rare |
Appetite lost | Uncommon |
Arrhythmia | Rare |
Arthralgia (Pain joint) (Joint ache) | Very rare |
AST increased | Very rare |
Back pain | Very rare |
Blood cholesterol increased | Common |
Blood sodium decreased | Not known |
Blood triglycerides increased | Common |
Bone marrow depression | Rare |
Cephalea | Very rare |
Constipation | Uncommon |
Cutaneous lupus erythematosus-like reactions | Rare |
Cutaneous vasculitis | Rare |
Depression | Rare |
Diarrhoea (Diarrhea) | Uncommon |
Fever | Rare |
Gastric irritation (Stomach irritation) | Uncommon |
Glucosuria (Glycosuria) | Common |
Haemoglobin decreased | Very rare |
Haemolytic anemia | Rare |
Hepatic dysfunction | Very rare |
Hepatic enzyme increased | Very rare |
Hepatitis | Very rare |
Hyperglycaemia | Common |
Hyperkalaemia | Very rare |
Hyperuricaemia | Common |
Hypokalaemia | Common |
Hyponatraemia (Hyponatremia) | Common |
Interstitial nephritis | Rare |
Intrahepatic cholestatic jaundice | Rare |
Kidney function abnormal | Very rare |
Leucopenia (Leukopenia) | Very rare |
Lightheadedness | Common |
Lung disease | Rare |
Lyell Syndrome (Toxic epidermal necrolysis) | Rare |
Muscle spasms | Rare |
Myalgia | Very rare |
Nausea | Very rare |
Necrotizing angiitis | Rare |
Neutropenia | Very rare |
Orthostatic hypotension | Uncommon |
Pancreatitis | Rare |
Paraesthesia (paresthesia) | Rare |
Photosensitivity | Uncommon |
Platelet count decreased (Thrombocyte count decreased) | Rare |
Pruritus | Very rare |
Pulmonary oedema | Rare |
Reactivation of cutaneous lupus erythematosus | Rare |
Renal insufficiency | Very rare |
Respiratory distress | Rare |
Serum creatinine increased | Not known |
Serum potassium increased | Not known |
Serum urea increased | Common |
Skin Eruption | Uncommon |
Sleep disorder (Sleep disturbance) | Rare |
Urticaria | Uncommon |
Vasculitis | Rare |
Vertigo | Common |
Vision blurred | Rare |
Weakness | Common |
NB : Products With Same Indication |
Different Units By MoH Code
pms-Candesartan HCTZ MoH 9080 :
Form | Tablet |
Package Size | Box of 30 |
Strength | 16mg/12.5mg |
Storage Condition | 15-30°C Away from moisture |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 7017/1 |
Submission date | 13/01/2017 |
Registration Year | 2017 |
Archived Date | 19/10/2021 |
You have to register to view this info
Drop File